We are live on
!
Find out more
Axa Portfolio holdings
AUM
$256M
1-Year Est. Return
25.01%
This Fund
S&P 500
This Quarter
Est. Return
+2.35%
1 Year Est. Return
+25.01%
3 Year Est. Return
+86.3%
5 Year Est. Return
+113.69%
10 Year Est. Return
+471.75%
AUM
$24.3B
AUM Growth
-$663M
(-2.7%)
Cap. Flow
-$1.37B
Cap. Flow
% of AUM
-5.66%
Top 10 Holdings %
Top 10 Hldgs %
15.29%
Holding
1,567
New
158
Increased
553
Reduced
532
Closed
145
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$130M |
| 2 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$126M |
| 3 |
MetLife
MET
|
+$107M |
| 4 |
General Mills
GIS
|
+$92.4M |
| 5 |
Parker-Hannifin
PH
|
+$71.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$199M |
| 2 |
RTN
Raytheon Company
RTN
|
+$151M |
| 3 |
Delta Air Lines
DAL
|
+$148M |
| 4 |
Norfolk Southern
NSC
|
+$145M |
| 5 |
Boston Scientific
BSX
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.12% |
| 2 | Financials | 14.48% |
| 3 | Technology | 13.69% |
| 4 | Consumer Discretionary | 8.63% |
| 5 | Industrials | 8.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Bristol-Myers Squibb
BMY
$129B
| $43.3M | 0.18% |
671,648
+90,843
| +16% | +$5.69M |
|
152
iShares Expanded Tech Sector ETF
IGM
$9.57B
| $42.9M | 0.18% |
2,498,700
+27,600
| +1% | +$473K |
|
153
Altria Group
MO
$125B
| $42.9M | 0.18% |
858,229
-109,524
| -11% | -$5.81M |
|
154
GameStop
GME
$9.8B
| $42.3M | 0.17% |
4,456,880
+1,797,280
| +68% | +$16.9M |
|
155
Nasdaq
NDAQ
$53.4B
| $42.1M | 0.17% |
+2,480,223
| New | +$40.4M |
|
156
Incyte
INCY
$25.4B
| $42.1M | 0.17% |
458,966
+44,356
| +11% | +$3.67M |
|
157
Lam Research
LRCX
$316B
| $42M | 0.17% |
5,984,560
-145,240
| -2% | -$1.15M |
|
158
PG&E
PCG
$39B
| $41.7M | 0.17% |
786,500
+3,100
| +0.4% | +$171K |
|
159
McKesson
MCK
$104B
| $41.3M | 0.17% |
182,520
+9,331
| +5% | +$2.07M |
|
160
Amdocs
DOX
$6.03B
| $41.1M | 0.17% |
755,900
-574,049
| -43% | -$29M |
|
161
Tractor Supply
TSCO
$16.3B
| $41.1M | 0.17% |
2,416,570
+833,960
| +53% | +$13.9M |
|
162
Elevance Health
ELV
$81.5B
| $40.3M | 0.17% |
260,676
+74,781
| +40% | +$10.6M |
|
163
Omnicom Group
OMC
$23.5B
| $40M | 0.16% |
512,923
+81,559
| +19% | +$6.23M |
|
164
Marvell Technology
MRVL
$147B
| $38.8M | 0.16% |
2,641,970
-236,200
| -8% | -$3.73M |
|
165
US Bancorp
USB
$97.9B
| $37.9M | 0.16% |
868,731
-38,789
| -4% | -$1.7M |
|
166
Goldman Sachs
GS
$289B
| $37.7M | 0.16% |
200,368
-4,866
| -2% | -$905K |
|
167
Exelon
EXC
$48.1B
| $37.6M | 0.16% |
1,568,838
+575,521
| +58% | +$14.3M |
|
168
Magna International
MGA
$18.8B
| $37.3M | 0.15% |
697,300
-14,700
| -2% | -$757K |
|
169
Celanese
CE
$4.82B
| $36M | 0.15% |
645,123
-311,043
| -33% | -$17.6M |
|
170
Deluxe
DLX
$1.25B
| $35.7M | 0.15% |
515,975
-13,840
| -3% | -$901K |
|
|
ESRX
171
DELISTED
Express Scripts Holding Company
ESRX
| $35M | 0.14% |
403,688
-329
| -0.1% | -$27.6K |
|
172
Lumen
LUMN
$6.43B
| $34M | 0.14% |
984,468
+748,005
| +316% | +$27.9M |
|
173
iShares MSCI EAFE ETF
EFA
$76.4B
| $33.9M | 0.14% |
528,907
-295,900
| -36% | -$18.6M |
|
174
Occidental Petroleum
OXY
$55.7B
| $33.9M | 0.14% |
464,709
+151,314
| +48% | +$11.7M |
|
|
SKX
175
DELISTED
Skechers
SKX
| $33.6M | 0.14% |
1,400,340
+416,394
| +42% | +$8.96M |
|
Similar funds
PHAM
HFRG
EBWM
GCCM
CIA
KAM
ACM
CCA
Axa's Q1 2015 Portfolio in Review
As of Q1 2015, Axa held 1,567 positions worth $24.3B, down 2.7% from $24.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Axa withdrew a net $1.37B in Q1 2015, closing 145 positions and reducing 532 holdings. Its most notable exit was Viatris, an estimated $55.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 17% a quarter earlier, followed by Financials and Technology.
Against the trend, Axa opened a new position in Nasdaq worth $42.1M.
- Axa's largest Q1 2015 buy was Nasdaq: 2,480,223 shares worth $42.1M.
- Axa added most to Johnson & Johnson in Q1 2015, an estimated $130M increase.
- Axa's biggest Q1 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $199M.
- Axa fully exited Viatris in Q1 2015, selling an estimated $55.8M.
- Axa's ten largest holdings make up 15% of its $24.3B portfolio in Q1 2015.
- Axa opened 158 new positions and closed 145 in Q1 2015.
- Axa's portfolio value fell 2.7% quarter-over-quarter to $24.3B.
Based on Axa's 13F filing for Q1 2015, filed 13 May 2015.